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journal homepage: www.e lsev ier .com/ locate /yse izLetter to the EditorSenile myoclonic epilepsy in Down syndrome
I read with interest the recent paper by Dr. De Simone et al. on
senile myoclonic epilepsy in Down syndrome (DS),1 a condition
which they have studied over a number of years,2–4 and which
has been reported by other groups,5,6 sometimes under the rubric
of ‘‘late-onset myoclonic epilepsy in Down syndrome’’ (LOMEDS).
As part of ongoing studies of DS patients seen in the Cognitive
Function Clinic (CFC) at the regional neuroscience centre in
Liverpool, and in general neurological clinics undertaken by one
consultant neurologist,7 records of all DS patients seen over a 9-
year-period (January 2002–December 2010 inclusive) were
reviewed. Following De Simone et al.,1 diagnosis of senile
myoclonic epilepsy was based on the observation of both
progressive cognitive decline or frank dementia and myoclonic
jerks, particularly on awakening.
There were 24 referrals involving a total of 19 DS patients (one
patient referred twice, two patients referred 3 times) identiﬁed
from clinic records (M:F = 9:10; age range at ﬁrst referral 21–64
years, median = 47 years) from a total of 9468 new patient
consultations (=0.20%). Although the number of DS cases is small,
nonetheless this may represent over 10% of the estimated total
number of DS patients aged 18–64 in Liverpool.8 Of these 19 DS
patients, 13 had attended general neurology clinics (13/
8168 = 0.16%) and 6 had attended the CFC (6/1300 = 0.46%).
Of those 13 patients attending the general neurology clinic, all
but one was referred for episodes of loss of consciousness, the
exception being a patient with limb tremor who was being treated
with valproate formood stabilization. Ten patientswere diagnosed
with epilepsy, the other two with syncopal events. Seven of the
patients, all with epilepsy, also had a history of cognitive decline
sufﬁcient to amount to dementia. Of these, 3 had myoclonus and
tonic-clonic seizures.
Those patients attending CFC were all referred for perceived
cognitive decline; all 6 were diagnosed with dementia. Two of
these patients also had epileptic seizures but without a history of
myoclonic jerks, another had myoclonic jerks but not seizures.
Hence, both cognitive decline and myoclonus, sufﬁcient for a
diagnosis of senile myoclonic epilepsy,1 were observed in four
patients (=21%). A further six patients had cognitive decline and
epileptic seizures but with no report or observation of myoclonus.
As De Simone et al. note,1 the latter may be overlooked, in which
case these six patients may also have had senile myoclonic
epilepsy. If so, the frequency of this condition rises to 53% (=10/19).
The shortcomings of the current data notwithstanding, it is evident
that senile myoclonic epilepsy in DS is not a rarity.1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.01.020Epileptogenesis in senile myoclonic epilepsy in DS is presum-
ably similar to that in AD patients.9 Overexpression of amyloid b-
peptide (Ab) species derived from the amyloid precursor protein
(APP) gene on chromosome 21, present in three copies in DS, is
thought to be central to the development of AD brain pathology
which invariably develops after the age of 50 years.10 Myoclonus
and seizures are common in AD patients with presenilin 1 gene
mutations which increase Ab expression11 and there is a high
seizure frequency (>50%) in AD patients with APP duplications.12
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